Abstract:Transient gene expression (TGE) is a rapid method for the production of recombinant proteins in mammalian cells. While the volumetric productivity of TGE has improved significantly over the past decade, most methods involve extensive cell line engineering and plasmid vector optimization in addition to long fed batch cultures lasting up to 21 days. Our colleagues have recently reported the development of a CHO K1SV GS-KO host cell line. By creating a bi-allelic glutamine synthetase knock out of the original CHOK1SV host cell line, they were able to improve the efficiency of generating high producing stable CHO lines for drug product manufacturing. We developed a TGE method using the same CHO K1SV GS-KO host cell line without any further cell line engineering. We also refrained from performing plasmid vector engineering. Our objective was to setup a TGE process to mimic protein quality attributes obtained from stable CHO cell line. Polyethyleneimine (PEI)-mediated transfections were performed at high cell density (4 × 10(6) cells/mL) followed by immediate growth arrest at 32 °C for 7 days. Optimizing DNA and PEI concentrations proved to be important. Interestingly, found the direct transfection method (where DNA and PEI were added sequentially) to be superior to the more common indirect method (where DNA and PEI are first pre-complexed). Moreover, the addition of a single feed solution and a polar solvent (N,N dimethylacetamide) significantly increased product titers. The scalability of process from 2 mL to 2 L was demonstrated using multiple proteins and multiple expression volumes. Using this simple, short, 7-day TGE process, we were able to successfully produce 54 unique proteins in a fraction of the time that would have been required to produce the respective stable CHO cell lines. The list of 54 unique proteins includes mAbs, bispecific antibodies, and Fc-fusion proteins. Antibody titers of up to 350 mg/L were achieved with the simple 7-day process. Titers were increased to 1 g/L by extending the culture to 16 days. We also present two case studies comparing product quality of material generated by transient HEK293, transient CHO K1SV GS-KO, and stable CHO K1SV KO pool. Protein from transient CHO was more representative of stable CHO protein compared to protein produced from HEK293.

Transient Expression of Recombinant Spdgfr&#945;-Fc in CHO DG44 Cells Using 50-Ml Orbitally Shaking Disposable Bioreactors

Expression of Recombinant Spdgfrα-Fc in CHO and Its Anti-proliferation Analysis

Fermentation Optimization of an Anti-VEGFR2-MICA Fusion Protein Adopting Design of Experiments (DOE)

A high-titer scalable Chinese hamster ovary transient expression platform for production of biotherapeutics

[Construction, Expression and Purification of a Mammalian Secretory Recombinant Fusion Protein Rpc].

Integrated cell and process engineering for improved transient production of a "difficult-to-express" fusion protein by CHO cells

Scale-up of Procedure for Culture of Recombinant CHO Cells Expressing Tumor Necrosis Factor Receptor-Fc in Rotary Shaker and Determination of Biological Activity of Expressed Product

Synergistic promotion of transient transgene expression in CHO cells by PDI/XBP-1s co-transfection and mild hypothermia

In Vivo Validation of Biological Responses of Bfgf Released from Microspheres Formulated by Blending Poly-Lactide-co-Glycolide and Poly(ethylene Glycol)-Grafted-chitosan in Hamster Cheek Pouch Microcirculatory Models

Condition Optimization of PDGFR-β/Fc Transient Expression in HEK293F Cells

Engineering a Pharmacologically Superior Form of Granulocyte-Colony-stimulating Factor by Fusion with Gelatin-Like-protein Polymer.

Enhanced Transient Recombinant Protein Production in CHO Cells Through the Co‐transfection of the Product Gene with Bcl‐xL

Optimization of Condition for Transient Transfection of CHO-DG44 Cells

A high cell density transient transfection system for therapeutic protein expression based on a CHO GS-knockout cell line: process development and product quality assessment

Expression and purification of functional PDGF receptor beta

Reconstruction and Characterization of CHO Cells Transfected Bfgf Gene

CRISPR-Cas9 Mediated Stable Expression of Exogenous Proteins in the CHO Cell Line through Site-Specific Integration

High-level expression of recombinant IgG1 by CHO K1 platform

Engineering of Chinese Hamster Ovary Cells With NDPK-A to Enhance DNA Nuclear Delivery Combined With EBNA1 Plasmid Maintenance Gives Improved Exogenous Transient Reporter, mAb and SARS-CoV-2 Spike Protein Expression

High Level Expression, Efficient Purification and Bioactivity Assay of Recombinant Human Platelet-Derived Growth Factor AA Dimer (PDGF-AA) from Methylotrophic Yeast Pichia Pastoris.

Optimization of a transient antibody expression platform towards high titer and efficiency

Transient Expression of Recombinant Spdgfr&amp;#945;-Fc in CHO DG44 Cells Using 50-Ml Orbitally Shaking Disposable Bioreactors